Actively Recruiting
Secondary Sclerosis Cholangitis Prospective
Led by Medical University of Graz · Updated on 2024-10-09
380
Participants Needed
1
Research Sites
488 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
SC-CIP is increasing in patients after critical illness. Pathogenesis is still largely unclear. Gut microbiome composition, gut permeability, bacterial translocation, inflammation and/or genetic variants contribute to the pathogenesis The aim of this project is to study gut microbiome composition, gut permeability, bacterial translocation, inflammation, bile acid composition and genetic polymorphisms by conducting a prospective cohort study in patients with a high risk to develop SC-CIP.
CONDITIONS
Official Title
Secondary Sclerosis Cholangitis Prospective
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is willing and able to give informed consent for participation in the study OR "surrogate consent" by the institutional review board.
- Age above 18 years
- Mechanical ventilation or extracorporeal membrane oxygenation ≥ 5 days
You will not qualify if you...
- Primary or secondary sclerosing cholangitis diagnosed before current ICU admission
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University Graz
Graz, Austria
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here